MMP9 and breast carcinoma: Pretreatment of casticin on MDA-MB-231 and 4T1 cells resulted in downregulation of MMP-9 mRNA protein expression but has no significant effect on MMP-2, suggesting that casticin can suppress both migration and invasion abilities in breast cancer cells.